Qi Zhao
Principal Scientist BioNTech
Seminars
Tuesday 19th May 2026
Integrating Cutting-Edge Technologies, Including Multi-Omics & AIDriven Data, to Advance Potent Personalized TCR-Based Therapies
5:00 pm
- Personalized TCRs are both achievable and practical, offering great potential to broaden patient populations
- Enhanced TCR targetability and potency through the integration of multi-omics data
- Leveraging AI to predict TCR-pMHC folding structures, guiding TCR specificity and enhancing target diversity
